Rapid and Extensive Expansion in the United States of a New Multidrug-resistant Escherichia coli Clonal Group, Sequence Type 1193.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 29961843.
- Also identified by DOI 10.1093/cid/ciy525 and PMC identifier 6321845.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe the rapid and ongoing emergence across multiple US cities of a new multidrug-resistant Escherichia coli clone-sequence type (ST) 1193-resistant to fluoroquinolones (100%), trimethoprim-sulfamethoxazole (55%), and tetracycline (53%). ST1193 is associated with younger adults (age <40 years) and currently comprises a quarter of fluoroquinolone-resistant clinical E. coli urine isolates.
Medical subject headings
- Communicable Diseases, Emerging
- Drug Resistance, Multiple, Bacterial
- Escherichia coli
- Escherichia coli Infections